Registered entities
Anacor Pharmaceuticals, Inc.
Reg. No. 251854385United States
Innovation
75 patent families (38 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies; filing pace slowing. Cited 12,476 times.
| Year | Filings |
|---|---|
| 2015 | 20 |
| 2016 | 20 |
| 2017 | 27 |
| 2018 | 19 |
| 2019 | 16 |
| 2020 | 17 |
| 2021 | 16 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 20.3K social following, 4 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include GSK.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 60% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 3 | 30% |